2017
DOI: 10.1007/s00330-017-4766-3
|View full text |Cite
|
Sign up to set email alerts
|

Non-specific benign pathological results on transthoracic core-needle biopsy: how to differentiate false-negatives?

Abstract: • The negative predictive value of the non-specific benign biopsy was 89.4%. • A part-solid nodule is a significant predictor for false-negative biopsy (OR = 3.95). • Pathological diagnosis of granulomatous inflammation is a robust indicator for 'true-negatives'. • Identifying needle tip within target lesions is a significant predictor for 'true-negatives'.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
52
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 40 publications
(61 citation statements)
references
References 30 publications
4
52
0
Order By: Relevance
“…Malignancies appear to be more frequent in sub‐solid nodules than in solid nodules . Most sub‐solid lung nodules tend to correspond to early‐stage lung cancer or precancerous lesions .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Malignancies appear to be more frequent in sub‐solid nodules than in solid nodules . Most sub‐solid lung nodules tend to correspond to early‐stage lung cancer or precancerous lesions .…”
Section: Discussionmentioning
confidence: 99%
“…Malignancies appear to be more frequent in sub-solid nodules than in solid nodules. 10,11 Most sub-solid lung nodules tend to correspond to early-stage lung cancer or precancerous lesions. [7][8][9] Surgical resection may provide nearly 100% disease-free survival for patients with sub-solid lung nodules.…”
Section: Discussionmentioning
confidence: 99%
“…LN is defined as a round or oval lesion ≤ 3 cm that is completely surrounded by pulmonary parenchyma without other abnormalities [1][2][3][4]. CNB-based benign results can be divided into specific and non-specific benign results [10]. Specific benign results were defined as benign tumors or infectious diseases with identified pathogens.…”
Section: Definitionsmentioning
confidence: 99%
“…CNB-based benign results were considered to be true-negatives if the lesions were benign upon final 6 diagnosis. A final benign diagnosis could be made in 1 of the 3 ways: (a) surgery; (b) determination of a specific benign lesion upon pathological analysis of the lung biopsy sample; or (c) a decrease > 20% in lesion diameter, stability in size (without anticancer treatment) over a minimum of 2 years [10]. If lesions did not meet the criteria mentioned above, final diagnoses were listed as non-diagnostic lesions.…”
Section: Definitionsmentioning
confidence: 99%
See 1 more Smart Citation